+86 400-821-9890

CTONG-OrigiMed New Clinical Trial Sharing Platform Launched during the 3rd OrigiMed Summit for Cancer Discovery

May 24, 2019

With fast advances in the medical industry, on May 11, 2019, the third OrigiMed Summit for Cancer Discovery: Immunotherapy and Targeted Therapy was successfully held in Guangzhou. The summit was sponsored by the Chinese Thoracic Oncology Group (CTONG) and the International Cholangiocarcinoma Research Network (ICRN) and organized by OrigiMed (Shanghai) Ltd. At the summit, CTONG and OrigiMed jointly announced the establishment of a new sharing clinical trial platform, representing a new milestone in the strategic cooperation between CTONG and OrigiMed.


Launch of Special Chinese Big Data Platform for Cancer Genomics Informatics to Accelerate Innovation and Development of China's Precision Diagnosis and Treatment

Sep 28, 2018

豪享彩票 On September 21, 2018, the CSCO precision medicine international session with the theme of "All-Round Research by Experts for Further Study", hosted by the Chinese Society of Clinical Oncology (CSCO) and organized solely by OrigiMed Co., Ltd., was successfully held in Xiamen. At the conference, Beijing Xisike (CSCO) Clinical Oncology Research Foundation, East Clinical Center of Ontology and OrigiMed Co., Ltd jointly launched the Special Chinese Big Data Platform for Cancer Genomics Informatics, with the aim of establishing a special oncology genetic information database for the Chinese population and accelerating the innovation and development of precision diagnosis and treatment.


OrigiMed Collaborates with Illumina to Further Develop and Promote its Advanced Clinical Molecular Tumor Applications

July 11, 2018

OrigiMed announces an agreement with Illumina in Shanghai, China. It will develop and promote its advanced molecular clinical tumor applications to the public based on the Next Generation Sequencing (NGS) technology of Illumina. This marks further cooperation between Illumina and Chinese enterprises. It also signals that genomics technology will play an increasingly important future role in the fast-developing market of precise diagnosis of cancer.


Second OrigiMed Summit for Cancer Discovery Held in Shanghai, Bringing Precision Medicine of China to Go Global

May 31, 2018

On May 26, 2018, the Second OrigiMed Summit for Cancer Discovery: Immunotherapy and Targeted Therapy was held in Shanghai. On the theme of "Broader Vision, Deeper Insight", Chinese and foreign experts and scholars in this summit carried out further discussion on such topics as tumor targeting and immunotherapy, aiming to benchmark China's precision treatment against international standards.

豪享彩票_安全购彩 豪享彩票_官网 豪享彩票|官方指定! 豪享彩票-豪享彩票 豪享彩票-豪享彩票